RZLT
Rezolute, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.58
+0.88%Aug 25, 2026, 07:52 UTC
Bank of America Corp DE reduced its stake in Rezolute, Inc. by 31.3% during the quarter, selling 1,354,699 shares, according to its Form 13F filing.
Source:Jun 2, 2026, 16:31 UTC
Rezolute, Inc. reported an interim update from its ongoing Phase 3 upLIFT study evaluating ersodetug in patients with tumor hyperinsulinism.
Source: